Differentiating diffuse World Health Organization grade II and IV astrocytomas with ex vivo magnetic resonance spectroscopy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurosurgery

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1227/NEU.0b013e31827b9c57PMID 23147779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Survival and treatment patterns of glioblastoma in the elderly: a population-based study.

  2012cited by this paper
• Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma.

  2012cited by this paper
• Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas

  2012cited by this paper
• Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study.

  2011cited by this paper
• Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. Clinical article.

  2011cited by this paper
• Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.

  2011cited by this paper
• in vivo MRSによって測定されるミオイノシトールおよびグリシンの相対含有量から得た星状細胞腫の非侵襲的悪性度

  2011cited by this paper
• MR‐visible lipids and the tumor microenvironment

  2011cited by this paper
• Choline metabolism in malignant transformation

  2011cited by this paper
• Non-invasive grading of astrocytic tumours from the relative contents of myo-inositol and glycine measured by in vivo MRS.

  2011cited by this paper
• The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.

  2011cited by this paper
• Low-grade gliomas in adults.

  2011cited by this paper
• Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.

  2010cited by this paper
• Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers

  2010cited by this paper
• 31P Magnetic resonance spectroscopic imaging with polarisation transfer of phosphomono‐ and diesters at 3 T in the human brain: relation with age and spatial differences

  2010cited by this paper
• Phosphatidylcholine Metabolic Transformation and Progression Signature as a Pharmacodynamic Biomarker

  2010cited by this paper
• icoshift: A versatile tool for the rapid alignment of 1D NMR spectra.

  2010cited by this paper
• Role of Proton Magnetic Resonance Spectroscopy in Differentiating Oligodendrogliomas from Astrocytomas

  2010cited by this paper
• Non‐invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in‐vivo 1H MRS at 1.5 Tesla confirmed by ex‐vivo high‐resolution magic‐angle spinning NMR

  2010cited by this paper
• Imaging of brain tumors: MR spectroscopy and metabolic imaging.

  2010cited by this paper
• Correlations between in vivo 1H MRS and ex vivo 1H HRMAS metabolite measurements in adult human gliomas

  2010cited by this paper
• Noninvasive detection of temozolomide in brain tumor xenografts by magnetic resonance spectroscopy.

  2010cited by this paper
• Survival comparison between glioblastoma multiforme and other incurable cancers.

  2010cited by this paper
• 1H HR‐MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas

  2009cited by this paper
• Surgical Resection of High-grade Gliomas in Eloquent Regions Guided by Blood Oxygenation Level Dependent Functional Magnetic Resonance Imaging, Diffusion Tensor Tractography, and Intraoperative Navigated 3D Ultrasound

  2009cited by this paper
• High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• 1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours

  2009cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

  2009cited by this paper
• UvA-DARE ( Digital Academic Repository ) Assessment of PLSDA cross validation

  2008cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Characterization of brain metastases using high‐resolution magic angle spinning MRS

  2008cited by this paper
• An investigation of human brain tumour lipids by high‐resolution magic angle spinning 1H MRS and histological analysis

  2008cited by this paper
• Efficient 1H to 31P polarization transfer on a clinical 3T MR system

  2008cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

  2006cited by this paper
• Evaluation of 31P high‐resolution magic angle spinning of intact tissue samples

  2006cited by this paper
• Performance of some variable selection methods when multicollinearity is present

  2005cited by this paper
• 1H and 13C HR‐MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas

  2004cited by this paper
• Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma

  2004cited by this paper
• 1H MR spectroscopy of brain tumours and masses

  2003cited by this paper
• Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy

  2003cited by this paper
• Proton magnetic resonance spectroscopy (1H MRS) of human brain tumours: assessment of differences between tumour types and its applicability in brain tumour categorization

  2003cited by this paper
• High‐resolution magic angle spinning MRS of breast cancer tissue

  2002cited by this paper
• Prognostic factors for survival in adult patients with cerebral low-grade glioma.

  2002cited by this paper
• MRI of the tumor microenvironment

  2002cited by this paper
• Correlation of myo-inositol levels and grading of cerebral astrocytomas.

  2000cited by this paper
• Proton NMR chemical shifts and coupling constants for brain metabolites

  2000cited by this paper
• Tumour phospholipid metabolism

  1999cited by this paper
• High‐resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla

  1999cited by this paper
• Comparison of in vivo1H MRS of human brain tumours with1H HR-MAS spectroscopy of intact biopsy samples in vitro

  1999cited by this paper
• In vivo phosphorus polarization transfer and decoupling from protons in three‐dimensional localized nuclear magnetic resonance spectroscopy of human brain

  1997cited by this paper
• Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.

  1996cited by this paper

• Mapping an Extended Metabolic Profile of Gliomas Using High-Resolution 31P MRSI at 7T

  2021cites this paper
• Метаболом головного мозга

  2020cites this paper
• Magnetic resonance spectroscopy for the study of cns malignancies

  2020cites this paper
• Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer

  2019influential citation
• Metabolomics—A Promising Approach to Pituitary Adenomas

  2019cites this paper
• Metabolomic prostate cancer fields in HRMAS MRS‐profiled histologically benign tissue vary with cancer status and distance from cancer

  2019cites this paper
• Phosphorus magnetic resonance spectroscopic imaging using flyback echo planar readout trajectories

  2018cites this paper
• Histopathologic Features in Relation to Pretreatment Tumor Growth in Patients with Glioblastoma.

  2018cites this paper
• Metabolomic signature of brain cancer

  2017cites this paper
• Microdosing, isotopic labeling, radiotracers and metabolomics: relevance in drug discovery, development and safety.

  2017cites this paper
• Applications of high‐resolution magic angle spinning MRS in biomedical studies II—Human diseases

  2017cites this paper
• Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.

  2016cites this paper
• Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS)

  2016cites this paper
• Magnetic Resonance for non-invasive evaluation of preclinical models of human brain tumors

  2015cites this paper
• Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy

  2015cites this paper
• Characterization of metabolites in infiltrating gliomas using <i>ex vivo</i> ¹H highâ•’resolution magic angle spinning spectroscopy

  2014cites this paper
• IDH1 R132H mutation generates a distinct phospholipid metabolite profile in glioma.

  2014cites this paper
• Impacts of MR spectroscopic imaging on glioma patient management

  2014cites this paper
• Characterization of metabolites in infiltrating gliomas using ex vivo 1H high-resolution magic angle spinning spectroscopy

  2014cites this paper
• MR Spectroscopic Imaging

  2014cites this paper
• Clinical protocols for 31P MRS of the brain and their use in evaluating optic pathway gliomas in children

  2014cites this paper